ArticleFrontiers in microbiomes2025
The EDEN ISS mobile test facility microbiome changes by cleaning and continued use.
Article in Frontiers in microbiomes, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Bioregenerative life support systems (BLSS) utilizing plants and/or microorganisms to provide the crew of a spacecraft with food, clean water, breathable air, and other amenities are likely to form key components of future long-distance spaceflight missions. Extensive testing and validation of such technologies are necessary before they can be implemented. EDEN ISS was a platform in Antarctica that tested various plant cultivation technologies for a BLSS. To ensure the continued operation of a BLSS, it is vital that plants remain healthy, which necessitates the monitoring of the plant production facility microbiome to ensure that pathogens are detected early and countermeasures can be engaged. Methods: Swab surface samples collected in the EDEN ISS Mobile Test Facility (MTF) during different campaigns were used to estimate the bioburden of the various surfaces via viable count. Isolates obtained from the cultivation of the surface samples were identified via partial 16S rRNA gene sequencing. Additionally, 16S amplicon sequencing was performed on DNA extracted directly from the swab samples to characterize the microbiome. Results and discussion: The results revealed that the bioburden of the different sampling positions was not significantly reduced by cleaning, indicating that the employed cleaning regime was unsuited in its current form to adequately lower the bioburden. Identification of the isolates, as well as the full microbiome, revealed mostly environmental genera. However, in both cases, genera containing plant as well as human pathogens, like
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.